+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Locked Nucleic Acids Market by Product Type (Kits, Oligonucleotides, Primers), Application (Fluorescence in Situ Hybridization, Microarray Analysis, Polymerase Chain Reaction), End User, Synthesis Method, Product Form - Global Forecast 2025-2030- Product Image
Locked Nucleic Acids Market by Product Type (Kits, Oligonucleotides, Primers), Application (Fluorescence in Situ Hybridization, Microarray Analysis, Polymerase Chain Reaction), End User, Synthesis Method, Product Form - Global Forecast 2025-2030- Product Image
Sale

Locked Nucleic Acids Market by Product Type (Kits, Oligonucleotides, Primers), Application (Fluorescence in Situ Hybridization, Microarray Analysis, Polymerase Chain Reaction), End User, Synthesis Method, Product Form - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6133422
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Locked nucleic acids (LNAs) are at the forefront of oligonucleotide chemistry, enabling significant advances in molecular diagnostics, gene expression profiling, and therapeutics. By introducing a structurally rigid ribose conformation, LNAs provide unmatched stability, specificity, and resilience, making them an essential component within the evolving landscape of next-generation sequencing, digital PCR, and precision medicine platforms.

Market Snapshot: Locked Nucleic Acid Market Dynamics

The locked nucleic acid market is poised for substantial growth, propelled by their integration into advanced sequencing technologies and high-sensitivity analytical assays. Adoption is high among genomic research centers and clinical laboratories, with new product developments driving faster detection and enhanced reliability in both research and therapeutic settings. As locked nucleic acids become crucial in applications requiring superior hybridization and nuclease resistance, manufacturers and end users alike are adapting workflows to leverage their unique chemical and functional strengths.

Scope & Segmentation Analysis

This report offers comprehensive coverage of the locked nucleic acid market, detailing its core product and application segments, synthesis methods, end-user dynamics, and regional demand patterns.

  • Product Types: Next generation sequencing kits, polymerase chain reaction kits, quantitative PCR kits, double stranded and single stranded oligonucleotides, a range of primers and probes, plus analytical, custom, design, and synthesis services.
  • Applications: Fluorescence in situ hybridization (chromogenic, fluorescent), microarray analysis (cDNA and oligonucleotide platforms), conventional/digital/quantitative polymerase chain reaction, and RNA interference (microRNA, siRNA).
  • End Users: Academic and research institutes, contract research organizations, diagnostics laboratories, pharmaceutical and biotech companies.
  • Synthesis Methods: Enzymatic (including RNase H mediated), in vitro transcription (SP6, T3, T7 RNA polymerases), and solid phase synthesis (H-phosphonate, phosphoramidite approaches).
  • Product Forms: Liquid and powder, impacting handling and storage protocols.
  • Regions: Americas (notably United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including major EU markets, UAE, Saudi Arabia, South Africa, and others); Asia Pacific (China, India, Japan, Australia, South Korea, and Southeast Asian regions).
  • Industry Players: Thermo Fisher Scientific Inc., QIAGEN N.V., Merck KGaA, Integrated DNA Technologies, LGC Biosearch Technologies, TriLink BioTechnologies, Eurofins Scientific, GenScript Biotech, Sangon Biotech, and Shanghai GenePharma.

Primary Keyword Focus: Locked Nucleic Acid

Key Takeaways for Decision-Makers

  • LNAs are transforming next-generation sequencing and digital PCR accuracy, allowing detection of low-abundance and rare genetic variants that were previously out of reach.
  • Diagnostic assays using LNA-modified primers and probes support improved sensitivity and specificity, raising the standard for early disease detection and molecular diagnostics.
  • Adoption rates are especially strong in clinical and translational research, with custom and design services catering to the diverse needs of academic, CRO, and industry stakeholders.
  • Synthesis strategies influence both turnaround times and cost, with regionalized production supporting supply chain resilience amid regulatory and tariff shifts.
  • Partnerships between innovators, contract manufacturers, and instrumentation providers are accelerating turnkey product launches and integrated analytical solutions.

Tariff Impact: 2025 United States Tariffs and Supply Chain Realignment

The 2025 imposition of tariffs on nucleic acid imports prompted manufacturers and suppliers to reassess global supply chains. Raw material costs rose, catalyzing domestic investments, local synthesis partnerships, and alternative sourcing strategies. Industry leaders responded by expanding domestic and regionally diversified production capabilities, simultaneously reducing lead times and enhancing quality control. These shifts have resulted in more resilient supply networks, allowing stakeholders to better manage regulatory environments and mitigate future trade volatility.

Methodology & Data Sources

Findings are supported by extensive reviews of peer-reviewed journals, patents, regulatory databases, and white papers, complemented by company disclosures and financial reports. Insights were validated through direct interviews with industry experts and cross-verified using external market intelligence, ensuring both contextual accuracy and a high level of data fidelity for strategic planning.

Why This Report Matters

  • Empowers leaders to optimize locked nucleic acid innovation, commercialization, and regulatory strategy while minimizing compliance risks.
  • Enables precise market entry and expansion planning through detailed segmentation and regional analysis tailored to supply chain, customer, and regulatory dynamics.
  • Supports C-suite and product strategists with actionable recommendations grounded in robust empirical data and expert perspectives.

Conclusion

Locked nucleic acids are shaping the trajectory of molecular research, diagnostics, and therapeutic innovation. Strategic adoption of robust manufacturing, diversified sourcing, and targeted partnerships will position stakeholders for sustained growth and competitive advantage.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of LNA applications in antisense oligonucleotide therapeutics pipeline boosting targeted disease treatments
5.2. Growing adoption of LNA modified probes in molecular diagnostics for enhanced assay sensitivity and specificity
5.3. Advances in LNA based miRNA detection platforms driving early cancer biomarker identification and prognostics
5.4. Strategic partnerships between LNA technology developers and pharma companies accelerating RNA therapy development
5.5. Regulatory milestones and emerging guidelines shaping clinical translation of LNA modified oligonucleotide therapeutics
5.6. Breakthroughs in cost efficient LNA synthesis techniques enabling large scale manufacturing and market expansion
5.7. Integration of LNA modified aptamers into targeted drug delivery systems for precision oncology treatments
5.8. Rising venture capital investments in LNA enabled gene editing tools to improve CRISPR specificity and outcomes
5.9. Development of LNA gapmers for neurological disorder therapies showing promising preclinical efficacy data and safety profiles
5.10. Collaboration between academic consortia and biotech firms optimizing LNA modifications for next generation vaccine adjuvants and diagnostics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Locked Nucleic Acids Market, by Product Type
8.1. Introduction
8.2. Kits
8.2.1. Next Generation Sequencing Kits
8.2.2. Polymerase Chain Reaction Kits
8.2.3. Quantitative PCR Kits
8.3. Oligonucleotides
8.3.1. Double Stranded
8.3.2. Single Stranded
8.4. Primers
8.4.1. Polymerase Chain Reaction Primers
8.4.2. Quantitative PCR Primers
8.4.3. Sequencing Primers
8.5. Probes
8.5.1. Fluorescence In Situ Hybridization Probes
8.5.2. Microarray Probes
8.5.3. Quantitative PCR Probes
8.6. Services
8.6.1. Analytical Services
8.6.2. Custom Services
8.6.3. Design Services
8.6.4. Synthesis Services
9. Locked Nucleic Acids Market, by Application
9.1. Introduction
9.2. Fluorescence In Situ Hybridization
9.2.1. Chromogenic Hybridization
9.2.2. Fluorescent Hybridization
9.3. Microarray Analysis
9.3.1. cDNA Microarray
9.3.2. Oligonucleotide Microarray
9.4. Polymerase Chain Reaction
9.4.1. Conventional Polymerase Chain Reaction
9.4.2. Digital Polymerase Chain Reaction
9.4.3. Quantitative Polymerase Chain Reaction
9.5. RNA Interference
9.5.1. MicroRNA
9.5.2. Small Interfering RNA
10. Locked Nucleic Acids Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Diagnostics Laboratories
10.5. Pharmaceutical And Biotechnology Companies
11. Locked Nucleic Acids Market, by Synthesis Method
11.1. Introduction
11.2. Enzymatic Synthesis
11.2.1. RNase H Mediated
11.3. In Vitro Transcription
11.3.1. SP6 RNA Polymerase
11.3.2. T3 RNA Polymerase
11.3.3. T7 RNA Polymerase
11.4. Solid Phase Synthesis
11.4.1. H-Phosphonate Approach
11.4.2. Phosphoramidite Approach
12. Locked Nucleic Acids Market, by Product Form
12.1. Introduction
12.2. Liquid
12.3. Powder
13. Americas Locked Nucleic Acids Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Locked Nucleic Acids Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Locked Nucleic Acids Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. QIAGEN N.V.
16.3.3. Merck KGaA
16.3.4. Integrated DNA Technologies, Inc.
16.3.5. LGC Biosearch Technologies, Inc.
16.3.6. TriLink BioTechnologies, LLC
16.3.7. Eurofins Scientific SE
16.3.8. GenScript Biotech Corporation
16.3.9. Sangon Biotech (Shanghai) Co., Ltd.
16.3.10. Shanghai GenePharma Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. LOCKED NUCLEIC ACIDS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LOCKED NUCLEIC ACIDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LOCKED NUCLEIC ACIDS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LOCKED NUCLEIC ACIDS MARKET: RESEARCHAI
FIGURE 26. LOCKED NUCLEIC ACIDS MARKET: RESEARCHSTATISTICS
FIGURE 27. LOCKED NUCLEIC ACIDS MARKET: RESEARCHCONTACTS
FIGURE 28. LOCKED NUCLEIC ACIDS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LOCKED NUCLEIC ACIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY NEXT GENERATION SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE PCR KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE PCR KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DOUBLE STRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DOUBLE STRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SINGLE STRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SINGLE STRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION PRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION PRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE PCR PRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE PCR PRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SEQUENCING PRIMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SEQUENCING PRIMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE PCR PROBES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE PCR PROBES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ANALYTICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CUSTOM SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CUSTOM SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DESIGN SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DESIGN SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CHROMOGENIC HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CHROMOGENIC HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENT HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENT HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CDNA MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CDNA MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDE MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDE MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICRORNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICRORNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SMALL INTERFERING RNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SMALL INTERFERING RNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNASE H MEDIATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNASE H MEDIATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SP6 RNA POLYMERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SP6 RNA POLYMERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY T3 RNA POLYMERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY T3 RNA POLYMERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY T7 RNA POLYMERASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY T7 RNA POLYMERASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY H-PHOSPHONATE APPROACH, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY H-PHOSPHONATE APPROACH, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PHOSPHORAMIDITE APPROACH, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PHOSPHORAMIDITE APPROACH, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS LOCKED NUCLEIC ACIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES LOCKED NUCLEIC ACIDS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 214. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 215. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 216. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 217. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2018-2024 (USD MILLION)
TABLE 218. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2025-2030 (USD MILLION)
TABLE 219. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
TABLE 220. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2025-2030 (USD MILLION)
TABLE 221. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 222. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 223. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 226. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 227. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2018-2024 (USD MILLION)
TABLE 228. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2025-2030 (USD MILLION)
TABLE 229. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 230. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 231. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2018-2024 (USD MILLION)
TABLE 232. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2025-2030 (USD MILLION)
TABLE 233. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 236. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 237. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 238. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 239. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2018-2024 (USD MILLION)
TABLE 240. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2025-2030 (USD MILLION)
TABLE 241. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 242. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 243. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 244. CANADA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 245. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 250. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 251. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
TABLE 254. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2025-2030 (USD MILLION)
TABLE 255. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 256. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 257. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 260. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 261. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 264. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 265. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 270. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 271. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 272. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 273. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2018-2024 (USD MILLION)
TABLE 274. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2025-2030 (USD MILLION)
TABLE 275. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 276. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 277. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 278. MEXICO LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY MICROARRAY ANALYSIS, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY RNA INTERFERENCE, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY ENZYMATIC SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY IN VITRO TRANSCRIPTION, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY SOLID PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY KITS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PRIMERS, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY PROBES, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA LOCKED NUCLEIC ACIDS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Locked Nucleic Acids market report include:
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Merck KGaA
  • Integrated DNA Technologies, Inc.
  • LGC Biosearch Technologies, Inc.
  • TriLink BioTechnologies, LLC
  • Eurofins Scientific SE
  • GenScript Biotech Corporation
  • Sangon Biotech (Shanghai) Co., Ltd.
  • Shanghai GenePharma Co., Ltd.

Related Topics

Related Reports

Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025 - Product Image

Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025

  • Drug Pipelines
  • 280 Pages
  • Global
From
Nucleic Acid Labeling - Global Strategic Business Report - Product Image

Nucleic Acid Labeling - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Nucleic Acid Labeling Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Type, By Method (Enzymatic, Chemical), By Application (Sequencing), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Nucleic Acid Labeling Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Type, By Method (Enzymatic, Chemical), By Application (Sequencing), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Nucleic Acid Labeling Market Report 2025 - Product Image

Nucleic Acid Labeling Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Nucleic Acids for Molecular Diagnosis Market by Product (Instruments, Reagents and Kits, Services), Technology (Microarrays, Next Generation Sequencing, Pcr), Application, Nucleic Acid Type, End User - Global Forecast 2025-2030 - Product Image

Nucleic Acids for Molecular Diagnosis Market by Product (Instruments, Reagents and Kits, Services), Technology (Microarrays, Next Generation Sequencing, Pcr), Application, Nucleic Acid Type, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.